Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) and SCYNEXIS (NASDAQ:SCYX – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations.
Valuation and Earnings
This table compares Guardian Pharmacy Services and SCYNEXIS”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Guardian Pharmacy Services | $1.46 billion | 1.38 | $49.22 million | $0.83 | 48.58 |
| SCYNEXIS | $20.60 million | 1.87 | -$8.61 million | ($3.84) | -1.01 |
Analyst Recommendations
This is a summary of recent ratings and target prices for Guardian Pharmacy Services and SCYNEXIS, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Guardian Pharmacy Services | 0 | 2 | 7 | 0 | 2.78 |
| SCYNEXIS | 1 | 0 | 1 | 0 | 2.00 |
Guardian Pharmacy Services presently has a consensus price target of $42.83, indicating a potential upside of 6.22%. SCYNEXIS has a consensus price target of $24.00, indicating a potential upside of 520.16%. Given SCYNEXIS’s higher probable upside, analysts plainly believe SCYNEXIS is more favorable than Guardian Pharmacy Services.
Institutional & Insider Ownership
54.4% of SCYNEXIS shares are owned by institutional investors. 33.0% of Guardian Pharmacy Services shares are owned by insiders. Comparatively, 4.1% of SCYNEXIS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Profitability
This table compares Guardian Pharmacy Services and SCYNEXIS’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Guardian Pharmacy Services | 3.64% | 30.72% | 15.99% |
| SCYNEXIS | -41.79% | -57.16% | -39.48% |
Risk & Volatility
Guardian Pharmacy Services has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, SCYNEXIS has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500.
Summary
Guardian Pharmacy Services beats SCYNEXIS on 10 of the 14 factors compared between the two stocks.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
About SCYNEXIS
SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
